AtriCure (ATRC) Receivables - Other (2011 - 2012)
AtriCure's (ATRC) quarterly Receivables - Other came in at $892000.0 in Q2 2012, up 26.88% quarter-over-quarter from $703000.0 in Q4 2011.
Powered by 
Analysis
AtriCure (ATRC) Receivables - Other (2011 - 2012) Analysis & Trends
AtriCure (ATRC) has reported Receivables - Other for 2 consecutive years, with $892000.0 the latest figure, recorded in Q2 2012.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $892000.0 in Q2 2012; TTM through Jun 2012 was $892000.0, a N/A change from a year earlier, with the FY2011 full-year figure at $703000.0, changed N/A from the prior year.
- Receivables - Other was $892000.0 for Q2 2012 at AtriCure, up from $703000.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $892000.0 in Q2 2012 and troughed at $703000.0 in Q4 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn |